Spyre Therapeutics, Inc.

Report date
12/31/2020
Quarter
2020 Q4
Filed
2/11/2021
Shares
20,125
Value ($000)
158
Weight
0.0%
2020 Q2 - 2020 Q4 (2 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).